XML 226 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Mannitab Pharma Specialties (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Acquisitions        
Payment for acquisition, net of cash acquired   $ 29 $ 40 $ 236
M.B. Sugars and Pharmaceuticals Limited        
Acquisitions        
Percentage of acquiree 65.00%      
Payment for acquisition, net of cash acquired $ 22      
Other assets, preliminary amount recognized $ 22